Maegim한국어

인바이오

352940KOSDAQSector: Chemicals & Materials
₩1,994▼ 0.55%Market cap ₩21.7BAs of Jul 21, 2026 close · updated once daily
B
Grade B51.3 ptsTop 51% of 2,523 stocks
Financial strength
48.2
Growth momentum
50.2
Price attractiveness
55.5

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

1

Financial strength

48.2
How much debt does it carry relative to equity?
Debt-to-equity ratio
63.2%
✓ Above median · Top 47.9% in sector
Sector median 65.0%
Can it cover what's due within a year?
Current ratio
167.6%
✓ Above median · Top 43.4% in sector
Sector median 154.0%
How much of revenue becomes profit?
Operating margin
2.7%
✗ Below median · Top 57.8% in sector
Sector median 3.8%
How much did it earn on its own capital?
ROE (return on equity)
2.4%
✗ Below median · Top 58.1% in sector
Sector median 3.6%

Source filing: annual report (separate) — view original ↗

2

Growth momentum

50.2
How much did revenue grow in a year?
Revenue growth (YoY)
-4.8%
✗ Below median · Top 64% in sector
Sector median 0.3%
Has it grown steadily over three years?
Revenue 3-year CAGR
-0.3%
✓ Above median · Top 46.2% in sector
Sector median -1.5%
Did core profits grow in a year?
Operating income change (YoY)
-34.7%
✗ Below median · Top 71.5% in sector
Sector median -6.6%
Are core profits higher than three years ago?
Operating income change (3Y)
119.2%
✓ Above median · Top 17.4% in sector
Sector median -12.4%

Source filing: annual report (separate) — view original ↗

3

Price attractiveness

55.5
Is the price expensive relative to earnings?
P/E (price-to-earnings)
21.5x
✗ Below median · Top 51.3% in sector
Sector median P/E of profitable peers 13.5x · 28% loss-making
Is the price expensive relative to book value?
P/B (price-to-book)
0.51x
✓ Above median · Top 37.7% in sector
Sector median 0.69x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 266 stocks in Chemicals & Materials

S2A51B86C46D59F20